Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Pelizzari-Raymundo

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Structure-Based Drug Discovery of IRE1 ModulatorsDiana Pelizzari Raymundo, Leif A Eriksson, Eric Chevet, et al.
Trends in Cancer|August 31, 2020
Pharmacological Targeting of IRE1 in CancerDiana Pelizzari Raymundo, Dimitrios Doultsinos, Xavier Guillory, et al.
STAR Protocols|September 13, 2024
Protocol to generate two distinct standard-of-care murine glioblastoma models for evaluating novel combination therapiesRaphael Pineau, Pierre Jean Le Reste, Tony Avril, et al.
Computational and Structural Biotechnology Journal|April 25, 2022
Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein responseKosala N Amarasinghe, Diana Pelizzari-Raymundo, Antonio Carlesso, et al.
Communications Chemistry|January 4, 2024
Different binding modalities of quercetin to inositol-requiring enzyme 1 of S. cerevisiae and human lead to opposite regulationS Jalil Mahdizadeh, Johan Grandén, Diana Pelizzari-Raymundo, et al.
The Biochemical Journal|August 10, 2021
Structural and molecular bases to IRE1 activity modulationTimothy Langlais, Diana Pelizzari-Raymundo, Sayyed Jalil Mahdizadeh, et al.
Journal of Cellular and Molecular Medicine|July 6, 2023
Endoplasmic reticulum homeostasis-From molecules to organisms: Report on the 14th International Calreticulin Workshop, Saint Malo, FranceKetsia Bakambamba, Federico Di Modugno, Marianne Guilbard, et al.
EMBO Reports|February 22, 2024
IRE1 RNase controls CD95-mediated cell deathDiana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, et al.
Iscience|May 22, 2023
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatmentDiana Pelizzari-Raymundo, Dimitrios Doultsinos, Raphael Pineau, et al.
Cancers|December 8, 2019
The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated DegradationOlivier Mansier, Valérie Prouzet-Mauléon, Gwénaële Jégou, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Structure-Based Drug Discovery of IRE1 ModulatorsDiana Pelizzari Raymundo, Leif A Eriksson, Eric Chevet, et al.
Trends in Cancer|August 31, 2020
Pharmacological Targeting of IRE1 in CancerDiana Pelizzari Raymundo, Dimitrios Doultsinos, Xavier Guillory, et al.
STAR Protocols|September 13, 2024
Protocol to generate two distinct standard-of-care murine glioblastoma models for evaluating novel combination therapiesRaphael Pineau, Pierre Jean Le Reste, Tony Avril, et al.
Computational and Structural Biotechnology Journal|April 25, 2022
Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein responseKosala N Amarasinghe, Diana Pelizzari-Raymundo, Antonio Carlesso, et al.
Communications Chemistry|January 4, 2024
Different binding modalities of quercetin to inositol-requiring enzyme 1 of S. cerevisiae and human lead to opposite regulationS Jalil Mahdizadeh, Johan Grandén, Diana Pelizzari-Raymundo, et al.
The Biochemical Journal|August 10, 2021
Structural and molecular bases to IRE1 activity modulationTimothy Langlais, Diana Pelizzari-Raymundo, Sayyed Jalil Mahdizadeh, et al.
Journal of Cellular and Molecular Medicine|July 6, 2023
Endoplasmic reticulum homeostasis-From molecules to organisms: Report on the 14th International Calreticulin Workshop, Saint Malo, FranceKetsia Bakambamba, Federico Di Modugno, Marianne Guilbard, et al.
EMBO Reports|February 22, 2024
IRE1 RNase controls CD95-mediated cell deathDiana Pelizzari-Raymundo, Victoria Maltret, Manon Nivet, et al.
Iscience|May 22, 2023
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatmentDiana Pelizzari-Raymundo, Dimitrios Doultsinos, Raphael Pineau, et al.
Cancers|December 8, 2019
The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated DegradationOlivier Mansier, Valérie Prouzet-Mauléon, Gwénaële Jégou, et al.
Pageof 2